Two-Step Irradiance Better for Condyloma Acuminatum

This article originally appeared here.
Share this content:
Two-Step Irradiance Better for Condyloma Acuminatum
Two-Step Irradiance Better for Condyloma Acuminatum

TUESDAY, June 27, 2017 (HealthDay News) -- For patients with condyloma acuminatum (CA), a two-step irradiance schedule is associated with a significantly greater reduction in pain during treatment than single-dose cold compress, according to a study published online June 22 in Lasers in Surgery and Medicine.

Xiaonan Shao, M.D., from the Third Affiliated Hospital of Soochow University in Changzhou, China, and colleagues conducted a prospective study involving 114 CA patients randomized into Group A (two-step irradiance schedule) and Group B (single-dose cold compress). At five, 10, 15, and 20 minutes during each photodynamic therapy (PDT) the authors recorded the numeric rating scales (NRS) of patients' pain.

The researchers observed no significant difference in the cure rate of patients in the two groups (97.1 versus 95.8 percent; P = 1.000). There were significant differences in the NRS scores at different time points and the number of PDT sessions (F =198.233 and 165.224, respectively; P < 0.05). Patients in Group A had significantly lower NRS scores than those in Group B (F = 82.762; P < 0.0001). The NRS scores at different positions also differed significantly (F = 28.286; P < 0.0001) Compared with those of the vulva and crissum, the NRS scores of the penis were significantly lower (P < 0.05).

"Compared with single-dose cold compress, two-step irradiance schedule could more significantly reduce the patients' pain degree during treatment, especially for vulva and crissum," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »